← FDA DRUG APPROVALS

FDA ANDA · ANDA080966

PROBENECID

Sponsor: LANNETT

APPLICATION
ANDA080966
TYPE
ANDA
ORIGINAL APPROVAL
1976-07-29
LATEST ACTION
2006-05-15
ROUTE
ORAL
DOSAGE FORM
TABLET
MARKETING STATUS
Prescription

Products

PROBALANPrescription
PROBENECID 500MG · TABLET · ORAL

Approval history

2006-05-15Labeling · Supplement 23AP
1989-08-18Labeling · Supplement 18AP
1988-03-11Manufacturing (CMC) · Supplement 17AP
1976-07-29OriginalAP
VIEW ON DRUGS@FDA ↗

Related on SPEQ

Pharma industryGMP disciplineFDA drug shortagesFDA enforcement & recalls

Source: FDA Drugs@FDA. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data, not medical, legal, or regulatory advice.

Weekly Briefing

Get the Weekly GxP Briefing

Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.

Read a past issue →